-
1
-
-
84969908932
-
-
American Cancer Society
-
American Cancer Society (2015). Cancer Facts and Figures 2015. Available at http://www.cancer.org/acs/groups/content/@editorial/documents/document/ acspc-044552.pdf.
-
(2015)
Cancer Facts and Figures 2015
-
-
-
2
-
-
84900373381
-
Targeting the androgen receptor pathway in castration-resistant prostate cancer: Progresses and prospects
-
Ferraldeschi R, Welti J, Luo J, Attard G, de Bono JS. Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects. Oncogene 2014; 34: 1745-1757.
-
(2014)
Oncogene
, vol.34
, pp. 1745-1757
-
-
Ferraldeschi, R.1
Welti, J.2
Luo, J.3
Attard, G.4
De Bono, J.S.5
-
3
-
-
84948717393
-
Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer
-
Watson PA, Arora VK, Sawyers CL. Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer. Nat Rev Cancer 2015; 15: 701-711.
-
(2015)
Nat Rev Cancer
, vol.15
, pp. 701-711
-
-
Watson, P.A.1
Arora, V.K.2
Sawyers, C.L.3
-
4
-
-
84863723010
-
The mutational landscape of lethal castration-resistant prostate cancer
-
Grasso CS, Wu YM, Robinson DR, Cao X, Dhanasekaran SM, Khan AP et al. The mutational landscape of lethal castration-resistant prostate cancer. Nature 2012; 487: 239-243.
-
(2012)
Nature
, vol.487
, pp. 239-243
-
-
Grasso, C.S.1
Wu, Y.M.2
Robinson, D.R.3
Cao, X.4
Dhanasekaran, S.M.5
Khan, A.P.6
-
5
-
-
84930225081
-
Integrative clinical genomics of advanced prostate cancer
-
Robinson D, Van Allen EM, Wu YM, Schultz N, Lonigro RJ, Mosquera JM et al. Integrative clinical genomics of advanced prostate cancer. Cell 2015; 161: 1215-1228.
-
(2015)
Cell
, vol.161
, pp. 1215-1228
-
-
Robinson, D.1
Van Allen, E.M.2
Wu, Y.M.3
Schultz, N.4
Lonigro, R.J.5
Mosquera, J.M.6
-
6
-
-
84928405167
-
The evolutionary history of lethal metastatic prostate cancer
-
Gundem G, Van Loo P, Kremeyer B, Alexandrov LB, Tubio JM, Papaemmanuil E et al. The evolutionary history of lethal metastatic prostate cancer. Nature 2015; 520: 353-357.
-
(2015)
Nature
, vol.520
, pp. 353-357
-
-
Gundem, G.1
Van Loo, P.2
Kremeyer, B.3
Alexandrov, L.B.4
Tubio, J.M.5
Papaemmanuil, E.6
-
7
-
-
84879671701
-
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer
-
Lunardi A, Ala U, Epping MT, Salmena L, Clohessy JG, Webster KA et al. A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. Nat Genet 2013; 45: 747-755.
-
(2013)
Nat Genet
, vol.45
, pp. 747-755
-
-
Lunardi, A.1
Ala, U.2
Epping, M.T.3
Salmena, L.4
Clohessy, J.G.5
Webster, K.A.6
-
8
-
-
0033215472
-
Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgendependent tumors through a two-step process
-
Craft N, Chhor C, Tran C, Belldegrun A, DeKernion J, Witte ON et al. Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgendependent tumors through a two-step process. Cancer Res 1999; 59: 5030-5036.
-
(1999)
Cancer Res
, vol.59
, pp. 5030-5036
-
-
Craft, N.1
Chhor, C.2
Tran, C.3
Belldegrun, A.4
DeKernion, J.5
Witte, O.N.6
-
9
-
-
84880560009
-
A preclinical xenograft model identifies castration-tolerant cancer-repopulating cells in localized prostate tumors
-
Toivanen R, Frydenberg M, Murphy D, Pedersen J, Ryan A, Pook D et al. A preclinical xenograft model identifies castration-tolerant cancer-repopulating cells in localized prostate tumors. Sci Transl Med 2013; 5: 187ra171.
-
(2013)
Sci Transl Med
, vol.5
, pp. 187ra171
-
-
Toivanen, R.1
Frydenberg, M.2
Murphy, D.3
Pedersen, J.4
Ryan, A.5
Pook, D.6
-
10
-
-
84873738494
-
Adaptation or selection-mechanisms of castration-resistant prostate cancer
-
Zong Y, Goldstein AS. Adaptation or selection-mechanisms of castration-resistant prostate cancer. Nat Rev Urol 2013; 10: 90-98.
-
(2013)
Nat Rev Urol
, vol.10
, pp. 90-98
-
-
Zong, Y.1
Goldstein, A.S.2
-
11
-
-
33745512125
-
The clinical relevance of the metabolism of prostate cancer; Zinc and tumor suppression: Connecting the dots
-
Costello LC, Franklin RB. The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots. Mol Cancer 2006; 5: 17.
-
(2006)
Mol Cancer
, vol.5
, pp. 17
-
-
Costello, L.C.1
Franklin, R.B.2
-
13
-
-
84918573255
-
AKT1 and MYC induce distinctive metabolic fingerprints in human prostate cancer
-
Priolo C, Pyne S, Rose J, Regan ER, Zadra G, Photopoulos C et al. AKT1 and MYC induce distinctive metabolic fingerprints in human prostate cancer. Cancer Res 2014; 74: 7198-7204.
-
(2014)
Cancer Res
, vol.74
, pp. 7198-7204
-
-
Priolo, C.1
Pyne, S.2
Rose, J.3
Regan, E.R.4
Zadra, G.5
Photopoulos, C.6
-
14
-
-
84891706485
-
Molecular imaging of prostate cancer with PET
-
Jadvar H. Molecular imaging of prostate cancer with PET. J Nucl Med 2013; 54: 1685-1688.
-
(2013)
J Nucl Med
, vol.54
, pp. 1685-1688
-
-
Jadvar, H.1
-
15
-
-
84881557242
-
Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer
-
Patra KC, Wang Q, Bhaskar PT, Miller L, Wang Z, Wheaton W et al. Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer. Cancer Cell 2013; 24: 213-228.
-
(2013)
Cancer Cell
, vol.24
, pp. 213-228
-
-
Patra, K.C.1
Wang, Q.2
Bhaskar, P.T.3
Miller, L.4
Wang, Z.5
Wheaton, W.6
-
16
-
-
84922503253
-
Hexokinase 2-mediated Warburg effect is required for PTEN- and p53-deficiency-driven prostate cancer growth
-
Wang L, Xiong H, Wu F, Zhang Y, Wang J, Zhao L et al. Hexokinase 2-mediated Warburg effect is required for PTEN- and p53-deficiency-driven prostate cancer growth. Cell Reports 2014; 8: 1461-1474.
-
(2014)
Cell Reports
, vol.8
, pp. 1461-1474
-
-
Wang, L.1
Xiong, H.2
Wu, F.3
Zhang, Y.4
Wang, J.5
Zhao, L.6
-
17
-
-
0024237766
-
Functional significance of mitochondrial bound hexokinase in tumor cell metabolism. Evidence for preferential phosphorylation of glucose by intramitochondrially generated ATP
-
Arora KK, Pedersen PL. Functional significance of mitochondrial bound hexokinase in tumor cell metabolism. Evidence for preferential phosphorylation of glucose by intramitochondrially generated ATP. J Biol Chem 1988; 263: 17422-17428.
-
(1988)
J Biol Chem
, vol.263
, pp. 17422-17428
-
-
Arora, K.K.1
Pedersen, P.L.2
-
18
-
-
9744221185
-
Hexokinasemitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak
-
Majewski N, Nogueira V, Bhaskar P, Coy PE, Skeen JE, Gottlob K et al. Hexokinasemitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol Cell 2004; 16: 819-830.
-
(2004)
Mol Cell
, vol.16
, pp. 819-830
-
-
Majewski, N.1
Nogueira, V.2
Bhaskar, P.3
Coy, P.E.4
Skeen, J.E.5
Gottlob, K.6
-
19
-
-
84921887492
-
Hexokinase II integrates energy metabolism and cellular protection: Akting on mitochondria and TORCing to autophagy
-
Roberts DJ, Miyamoto S. Hexokinase II integrates energy metabolism and cellular protection: Akting on mitochondria and TORCing to autophagy. Cell Death Differ 2015; 22: 364.
-
(2015)
Cell Death Differ
, vol.22
, pp. 364
-
-
Roberts, D.J.1
Miyamoto, S.2
-
20
-
-
84946195510
-
The molecular taxonomy of primary prostate cancer
-
Cancer Genome Atlas Research Network
-
Cancer Genome Atlas Research Network, The molecular taxonomy of primary prostate cancer. Cell 2015; 163: 1011-1025.
-
(2015)
Cell
, vol.163
, pp. 1011-1025
-
-
-
21
-
-
84868446982
-
Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancer
-
Chaux A, Peskoe SB, Gonzalez-Roibon N, Schultz L, Albadine R, Hicks J et al. Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancer. Mod Pathol 2012; 25: 1543-1549.
-
(2012)
Mod Pathol
, vol.25
, pp. 1543-1549
-
-
Chaux, A.1
Peskoe, S.B.2
Gonzalez-Roibon, N.3
Schultz, L.4
Albadine, R.5
Hicks, J.6
-
22
-
-
53849146755
-
Is PTEN loss associated with clinical outcome measures in human prostate cancer?
-
McCall P, Witton CJ, Grimsley S, Nielsen KV, Edwards J. Is PTEN loss associated with clinical outcome measures in human prostate cancer? Br J Cancer 2008; 99: 1296-1301.
-
(2008)
Br J Cancer
, vol.99
, pp. 1296-1301
-
-
McCall, P.1
Witton, C.J.2
Grimsley, S.3
Nielsen, K.V.4
Edwards, J.5
-
23
-
-
80054111295
-
PTEN protein loss by immunostaining: Analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients
-
Lotan TL, Gurel B, Sutcliffe S, Esopi D, Liu W, Xu J et al. PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients. Clin Cancer Res 2011; 17: 6563-6573.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 6563-6573
-
-
Lotan, T.L.1
Gurel, B.2
Sutcliffe, S.3
Esopi, D.4
Liu, W.5
Xu, J.6
-
24
-
-
67650917081
-
PTEN genomic deletion is associated with p-Akt and AR signalling in poorer outcome, hormone refractory prostate cancer
-
Sircar K, Yoshimoto M, Monzon FA, Koumakpayi IH, Katz RL, Khanna et al. PTEN genomic deletion is associated with p-Akt and AR signalling in poorer outcome, hormone refractory prostate cancer. J Pathol 2009; 218: 505-513.
-
(2009)
J Pathol
, vol.218
, pp. 505-513
-
-
Sircar, K.1
Yoshimoto, M.2
Monzon, F.A.3
Koumakpayi, I.H.4
Katz, R.L.5
Khanna6
-
25
-
-
33748038440
-
Emergence of androgen independence at early stages of prostate cancer progression in Nkx3.1; Pten mice
-
Gao H, Ouyang X, Banach-Petrosky WA, Shen MM, Abate-Shen C. Emergence of androgen independence at early stages of prostate cancer progression in Nkx3.1; Pten mice. Cancer Res 2006; 66: 7929-7933.
-
(2006)
Cancer Res
, vol.66
, pp. 7929-7933
-
-
Gao, H.1
Ouyang, X.2
Banach-Petrosky, W.A.3
Shen, M.M.4
Abate-Shen, C.5
-
26
-
-
34447121369
-
Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development
-
Jiao J, Wang S, Qiao R, Vivanco I, Watson PA, Sawyers CL et al. Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development. Cancer Res 2007; 67: 6083-6091.
-
(2007)
Cancer Res
, vol.67
, pp. 6083-6091
-
-
Jiao, J.1
Wang, S.2
Qiao, R.3
Vivanco, I.4
Watson, P.A.5
Sawyers, C.L.6
-
27
-
-
79958764107
-
Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth
-
Mulholland DJ, Tran LM, Li Y, Cai H, Morim A, Wang S et al. Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth. Cancer Cell 2011; 19: 792-804.
-
(2011)
Cancer Cell
, vol.19
, pp. 792-804
-
-
Mulholland, D.J.1
Tran, L.M.2
Li, Y.3
Cai, H.4
Morim, A.5
Wang, S.6
-
28
-
-
84926330368
-
Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer
-
Hong MK, Macintyre G, Wedge DC, Van Loo P, Patel K, Lunke S et al. Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer. Nat Commun2015; 6: 6605.
-
(2015)
Nat Commun
, vol.6
, pp. 6605
-
-
Hong, M.K.1
Macintyre, G.2
Wedge, D.C.3
Van Loo, P.4
Patel, K.5
Lunke, S.6
-
30
-
-
84934281252
-
P53 in survival, death and metabolic health: A lifeguard with a licence to kill
-
Kruiswijk F, Labuschagne CF, Vousden KH. p53 in survival, death and metabolic health: a lifeguard with a licence to kill. Nat Rev Mol Cell Biol 2015; 16: 393-405.
-
(2015)
Nat Rev Mol Cell Biol
, vol.16
, pp. 393-405
-
-
Kruiswijk, F.1
Labuschagne, C.F.2
Vousden, K.H.3
-
31
-
-
84949579885
-
Identification of different classes of luminal progenitor cells within prostate tumors
-
Agarwal S, Hynes PG, Tillman HS, Lake R, Abou-Kheir WG, Fang L et al. Identification of different classes of luminal progenitor cells within prostate tumors. Cell Rep 2015.
-
(2015)
Cell Rep
-
-
Agarwal, S.1
Hynes, P.G.2
Tillman, H.S.3
Lake, R.4
Abou-Kheir, W.G.5
Fang, L.6
-
32
-
-
80052461278
-
Prostate epithelial Pten/TP53 loss leads to transformation of multipotential progenitors and epithelial to mesenchymal transition
-
Martin P, Liu YN, Pierce R, Abou-Kheir W, Casey O, Seng V et al. Prostate epithelial Pten/TP53 loss leads to transformation of multipotential progenitors and epithelial to mesenchymal transition. Am J Pathol 2011; 179: 422-435.
-
(2011)
Am J Pathol
, vol.179
, pp. 422-435
-
-
Martin, P.1
Liu, Y.N.2
Pierce, R.3
Abou-Kheir, W.4
Casey, O.5
Seng, V.6
-
33
-
-
79960071366
-
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
-
Massie CE, Lynch A, Ramos-Montoya A, Boren J, Stark R, Fazli L et al. The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis. EMBO J 2011; 30: 2719-2733.
-
(2011)
EMBO J
, vol.30
, pp. 2719-2733
-
-
Massie, C.E.1
Lynch, A.2
Ramos-Montoya, A.3
Boren, J.4
Stark, R.5
Fazli, L.6
-
34
-
-
84868633053
-
Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B
-
Sun Y, Campisi J, Higano C, Beer TM, Porter P, Coleman I et al. Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nat Med 2012; 18: 1359-1368.
-
(2012)
Nat Med
, vol.18
, pp. 1359-1368
-
-
Sun, Y.1
Campisi, J.2
Higano, C.3
Beer, T.M.4
Porter, P.5
Coleman, I.6
-
35
-
-
33745298217
-
Protocadherin-PC promotes androgen-independent prostate cancer cell growth
-
Terry S, Queires L, Gil-Diez-de-Medina S, Chen MW, de la Taille A, Allory Y et al. Protocadherin-PC promotes androgen-independent prostate cancer cell growth. Prostate 2006; 66: 1100-1113.
-
(2006)
Prostate
, vol.66
, pp. 1100-1113
-
-
Terry, S.1
Queires, L.2
Gil-Diez-De-Medina, S.3
Chen, M.W.4
De La Taille, A.5
Allory, Y.6
-
36
-
-
79955975429
-
Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer
-
Carver BS, Chapinski C, Wongvipat J, Hieronymus H, Chen Y, Chandarlapaty S et al. Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer. Cancer Cell 2011; 19: 575-586.
-
(2011)
Cancer Cell
, vol.19
, pp. 575-586
-
-
Carver, B.S.1
Chapinski, C.2
Wongvipat, J.3
Hieronymus, H.4
Chen, Y.5
Chandarlapaty, S.6
-
37
-
-
80053943314
-
Self-renewing Pten-/- TP53-/- protospheres produce metastatic adenocarcinoma cell lines with multipotent progenitor activity
-
Abou-Kheir W, Hynes PG, Martin P, Yin JJ, Liu YN, Seng V et al. Self-renewing Pten-/- TP53-/- protospheres produce metastatic adenocarcinoma cell lines with multipotent progenitor activity. PLoS One 2011; 6: e26112.
-
(2011)
PLoS One
, vol.6
, pp. e26112
-
-
Abou-Kheir, W.1
Hynes, P.G.2
Martin, P.3
Yin, J.J.4
Liu, Y.N.5
Seng, V.6
-
38
-
-
84875497134
-
Metabolomic profiling of lung and prostate tumor tissues by capillary electrophoresis time-offlight mass spectrometry
-
Kami K, Fujimori T, Sato H, Sato M, Yamamoto H, Ohashi Y et al. Metabolomic profiling of lung and prostate tumor tissues by capillary electrophoresis time-offlight mass spectrometry. Metabolomics 2013; 9: 444-453.
-
(2013)
Metabolomics
, vol.9
, pp. 444-453
-
-
Kami, K.1
Fujimori, T.2
Sato, H.3
Sato, M.4
Yamamoto, H.5
Ohashi, Y.6
-
39
-
-
84883189700
-
Metabolomic signatures of aggressive prostate cancer
-
McDunn JE, Li Z, Adam KP, Neri BP, Wolfert RL, Milburn MV et al. Metabolomic signatures of aggressive prostate cancer. Prostate 2013; 73: 1547-1560.
-
(2013)
Prostate
, vol.73
, pp. 1547-1560
-
-
McDunn, J.E.1
Li, Z.2
Adam, K.P.3
Neri, B.P.4
Wolfert, R.L.5
Milburn, M.V.6
-
40
-
-
79952937101
-
H HRMAS NMR derived bio-markers related to tumor grade, tumor cell fraction, and cell proliferation in prostate tissue samples
-
Stenman K, Stattin P, Stenlund H, Riklund K, Grobner G, Bergh A. H HRMAS NMR derived bio-markers related to tumor grade, tumor cell fraction, and cell proliferation in prostate tissue samples. Biomark Insights 2011; 6: 39-47.
-
(2011)
Biomark Insights
, vol.6
, pp. 39-47
-
-
Stenman, K.1
Stattin, P.2
Stenlund, H.3
Riklund, K.4
Grobner, G.5
Bergh, A.6
-
41
-
-
0242353960
-
Proton HR-MAS spectroscopy and quantitative pathologic analysis of MRI/3DMRSI- targeted postsurgical prostate tissues
-
Swanson MG, Vigneron DB, Tabatabai ZL, Males RG, Schmitt L, Carroll PR et al. Proton HR-MAS spectroscopy and quantitative pathologic analysis of MRI/3DMRSI- targeted postsurgical prostate tissues. Magn Reson Med 2003; 50: 944-954.
-
(2003)
Magn Reson Med
, vol.50
, pp. 944-954
-
-
Swanson, M.G.1
Vigneron, D.B.2
Tabatabai, Z.L.3
Males, R.G.4
Schmitt, L.5
Carroll, P.R.6
-
42
-
-
0034983918
-
Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase
-
Gottlob K, Majewski N, Kennedy S, Kandel E, Robey RB, Hay N. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev 2001; 15: 1406-1418.
-
(2001)
Genes Dev
, vol.15
, pp. 1406-1418
-
-
Gottlob, K.1
Majewski, N.2
Kennedy, S.3
Kandel, E.4
Robey, R.B.5
Hay, N.6
-
43
-
-
63649100705
-
Voltage-dependent anion channel 1-based peptides interact with hexokinase to prevent its antiapoptotic activity
-
Arzoine L, Zilberberg N, Ben-Romano R, Shoshan-Barmatz V. Voltage-dependent anion channel 1-based peptides interact with hexokinase to prevent its antiapoptotic activity. J Biol Chem 2009; 284: 3946-3955.
-
(2009)
J Biol Chem
, vol.284
, pp. 3946-3955
-
-
Arzoine, L.1
Zilberberg, N.2
Ben-Romano, R.3
Shoshan-Barmatz, V.4
-
44
-
-
0038721560
-
Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone
-
Roudier MP, True LD, Higano CS, Vesselle H, Ellis W, Lange P et al. Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone. Hum Pathol 2003; 34: 646-653.
-
(2003)
Hum Pathol
, vol.34
, pp. 646-653
-
-
Roudier, M.P.1
True, L.D.2
Higano, C.S.3
Vesselle, H.4
Ellis, W.5
Lange, P.6
-
45
-
-
10844235652
-
Androgen-independent prostate cancer is a heterogeneous group of diseases: Lessons from a rapid autopsy program
-
Shah RB, Mehra R, Chinnaiyan AM, Shen R, Ghosh D, Zhou M et al. Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program. Cancer Res 2004; 64: 9209-9216.
-
(2004)
Cancer Res
, vol.64
, pp. 9209-9216
-
-
Shah, R.B.1
Mehra, R.2
Chinnaiyan, A.M.3
Shen, R.4
Ghosh, D.5
Zhou, M.6
-
46
-
-
84863456083
-
Hexokinase II knockdown results in exaggerated cardiac hypertrophy via increased ROS production
-
Wu R, Wyatt E, Chawla K, Tran M, Ghanefar M, Laakso M et al. Hexokinase II knockdown results in exaggerated cardiac hypertrophy via increased ROS production. EMBO Mol Med 2012; 4: 633-646.
-
(2012)
EMBO Mol Med
, vol.4
, pp. 633-646
-
-
Wu, R.1
Wyatt, E.2
Chawla, K.3
Tran, M.4
Ghanefar, M.5
Laakso, M.6
-
47
-
-
33746927077
-
Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt
-
Robey RB, Hay N. Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt. Oncogene 2006; 25: 4683-4696.
-
(2006)
Oncogene
, vol.25
, pp. 4683-4696
-
-
Robey, R.B.1
Hay, N.2
-
48
-
-
0347986675
-
Akt inhibits apoptosis downstream of BID cleavage via a glucose-dependent mechanism involving mitochondrial hexokinases
-
Majewski N, Nogueira V, Robey RB, Hay N. Akt inhibits apoptosis downstream of BID cleavage via a glucose-dependent mechanism involving mitochondrial hexokinases. Mol Cell Biol 2004; 24: 730-740.
-
(2004)
Mol Cell Biol
, vol.24
, pp. 730-740
-
-
Majewski, N.1
Nogueira, V.2
Robey, R.B.3
Hay, N.4
-
49
-
-
0036510541
-
Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis
-
Pastorino JG, Shulga N, Hoek JB. Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. J Biol Chem 2002; 277: 7610-7618.
-
(2002)
J Biol Chem
, vol.277
, pp. 7610-7618
-
-
Pastorino, J.G.1
Shulga, N.2
Hoek, J.B.3
-
50
-
-
46649106720
-
Hexokinase II detachment from mitochondria triggers apoptosis through the permeability transition pore independent of voltage-dependent anion channels
-
Chiara F, Castellaro D, Marin O, Petronilli V, Brusilow WS, Juhaszova M et al. Hexokinase II detachment from mitochondria triggers apoptosis through the permeability transition pore independent of voltage-dependent anion channels. PLoS One 2008; 3: e1852.
-
(2008)
PLoS One
, vol.3
, pp. e1852
-
-
Chiara, F.1
Castellaro, D.2
Marin, O.3
Petronilli, V.4
Brusilow, W.S.5
Juhaszova, M.6
-
51
-
-
84872454871
-
Effects of androgen deprivation therapy and bisphosphonate treatment on bone in patients with metastatic castration-resistant prostate cancer: Results from the University of Washington Rapid Autopsy Series
-
Morrissey C, Roudier MP, Dowell A, True LD, Ketchanji M, Welty C et al. Effects of androgen deprivation therapy and bisphosphonate treatment on bone in patients with metastatic castration-resistant prostate cancer: results from the University of Washington Rapid Autopsy Series. J Bone Miner Res 2013; 28: 333-340.
-
(2013)
J Bone Miner Res
, vol.28
, pp. 333-340
-
-
Morrissey, C.1
Roudier, M.P.2
Dowell, A.3
True, L.D.4
Ketchanji, M.5
Welty, C.6
-
52
-
-
68849083050
-
Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems
-
Evans AM, DeHaven CD, Barrett T, Mitchell M, Milgram E. Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem 2009; 81: 6-6667.
-
(2009)
Anal Chem
, vol.81
, pp. 6-6667
-
-
Evans, A.M.1
DeHaven, C.D.2
Barrett, T.3
Mitchell, M.4
Milgram, E.5
|